FAS and cancer: While senescence-inducing therapy could be an effective anti-cancer treatment strategy, systemic CD95 activation is not a realistic therapeutic approach as it causes rapid and lethal liver toxicity.42 Interestingly, MSI/CMS1-type tumors metastasize infrequently, but the fraction that does is highly aggressive30 and expresses relatively high levels of CD95 (unpublished observation).